Sources of variation in forced expiratory volume in one second and forced vital capacity

European Respiratory Journal

Volumn 27, Issue 4, 2006, Pages 767-773

  Chinn, Sue ^a   Jarvis, D ^a   Svanes, C ^b   Burney, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Height; Populations; Reference values; Spirometry

Indexed keywords

ACCURACY; ADULT; AGE; ANALYSIS OF VARIANCE; ANALYTICAL EQUIPMENT; ARTICLE; ASTHMA; BODY HEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; DATA ANALYSIS; ETHNIC DIFFERENCE; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; GEOGRAPHY; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; SEX DIFFERENCE; SPIROMETRY; STATISTICAL SIGNIFICANCE; WHEEZING; CLINICAL TRIAL; COMPARATIVE STUDY; CULTURAL FACTOR; MULTICENTER STUDY; REPRODUCIBILITY; STATISTICS; VITAL CAPACITY;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BODY HEIGHT; CROSS-CULTURAL COMPARISON; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SPIROMETRY; VITAL CAPACITY;

EID: 33750111341     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00073105     Document Type: Article

References (25)

1. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Anthonisen NR, Connett JE, Murray RP, for the Lung Health Study Research Group. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
3. Schünemann HJ, Grant BJB, Freudenheim JL, et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 2001; 163: 1246-1255.
4. Willemse BWM, Postma DS, Timens W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-476.
5. Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 1998; 11: 1354-1362.
6. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
7. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664.
8. Knudson RJ, Lebowitz MD, Holdberg CJ, Burrows B. Changes in normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
9. Paoletti P, Pistelli G, Fazzi P, et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Europ Physiopathol Respir 1986; 22: 451-459.
10. Castellsague J, Burgos F, Sunyer J, Barbera JA, Roca J. Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group onf Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey. Respir Med 1998; 92: 401-407.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
12. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
13. American Thoracic Society. Standardisation of spirometry. Am J Respir Crit Care Med 1995; 152: 1122.
14. Falaschetti E, Laiho J, Primatesta P, Purdon S. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004; 23: 456-463.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
16. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-560.
17. Vollmer WM, Johnson LR, McCamant LE, Buist AS. Longitudinal versus cross-sectional estimation of lung function decline: further insights. Stat Med 1988; 7: 685-696.
18. Vollmer WM, Johnson LR, McCamant LE, Buist AS. Methodologic issues in the analysis of lung function data. J Chronic Dis 1987; 40: 1013-1023.
19. Ware JH, Dockery DD, Louis TA, Xu X, Ferris BG, Speizer FE. Longitudinal and cross-sectional decline in never smoking adults. Am J Epidemiol 1990; 132: 685-700.
20. Gulsvik A, Tosteson T, Bakke P, Humerfelt S, Weiss ST, Speizer FE. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clin Physiol 2001; 21: 648-660.
21. Brändli O, Schindler CH, Künzli N, Keller R, Perruchoud AP. Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 1996; 51: 277-283.
22. Gore CJ, Crockett AJ, Pederson DG, Booth ML, Bauman A, Owen N. Spirometric standards for healthy adult lifetime nonsmokers in Australia. Eur Respir J 1995; 8: 773-782.
23. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag study. Eur Respir J 2001; 18: 770-779.
24. 1 due to technician, team, device and subject in an eight centre study. Eur Respir J 1995; 8: 371-376.
25. Künzli N, Kuna-Dibbert B, Keidel D, et al. Longitudinal validity of spirometers: a challenge in cohort studies. Swiss Med Wkly 2005; 135: 503-508.